Trevena
TRVN
#10609
Rank
ยฃ0 M
Marketcap
ยฃ0.009001
Share price
0.00%
Change (1 day)
-99.32%
Change (1 year)

Revenue for Trevena (TRVN)

Revenue in 2024 (TTM): ยฃ0.41 Million

According to Trevena's latest financial reports the company's current revenue (TTM ) is ยฃ0.4 Million. In 2023 the company made a revenue of ยฃ2.45 Million an increase over the revenue in the year 2022 that were of -ยฃ0.35 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Trevena from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) ยฃ0.41 M-82.88%
2023 ยฃ2.45 M-809.93%
2022 -ยฃ0.35 Million-182.25%
2021 ยฃ0.42 M-81.34%
2020 ยฃ2.25 M9424.04%
2019 ยฃ0.02 M-99.48%
2018 ยฃ4.51 M
2017 N/A-100%
2016 ยฃ3.03 M-27.94%
2015 ยฃ4.21 M
2014 N/A-100%
2013 ยฃ0.08 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
ยฃ26.98 B 6,587,995.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
ยฃ65.41 M 15,872.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
ยฃ5.35 M 1,207.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ48.18 B 11,764,552.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
ยฃ0.27 M-31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
ยฃ0.48 M 19.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
ยฃ75.3 M 18,288.28%๐Ÿ‡บ๐Ÿ‡ธ USA